BioCentury | Mar 25, 2021
Management Tracks

Slaoui resigns from Vaxcyte, Centessa; plus moves at HHS, Fate, Inotrem, Immuneering, SwanBio and more

...was a scientific co-founder of the company, succeeds Stan Abel, who will become SiteOne’s chairman. Diagnostics developer Cue Health Inc. hired...
...and managing partner of MRL Ventures Fund. BC Staff U.S. Department of Health and Human Services Fate Therapeutics Inc. Cue Health Inc. Inotrem...
BioCentury | Mar 17, 2021
Product Development

FDA gets explicit about asymptomatic screening tests

...outside of a testing program.” The March 5 authorization of a home test kit from Cue Health Inc....
...repeat home testing, which could enable more people to benefit from serial testing regimens. Karen Tkach Tuzman Cue Health Inc. U.S...
BioCentury | Mar 6, 2021
Product Development

Cue’s OTC home molecular test opens the door to routine self-screening

...for COVID-19 screening via a system that encourages repeat home testing.Performance metrics reported by manufacturer Cue Health Inc....
...positive samples from symptomatic users and 100% of positive samples from individuals without symptoms. Karen Tkach Tuzman Cue Health Inc. Lucira...
BioCentury | Nov 26, 2020
Product Development

U.S. government spending on Abbott BinaxNOW outstrips other rapid COVID-19 tests: Data Byte

...August , Abbott said it had shipped 7 million ID NOW tests.The COVID-19 molecular test from Cue Health Inc....
...tools for predicting who is most likely to spread SARS-CoV-2. Karen Tkach Tuzman Abbott Laboratories Becton Dickinson and Co. Cue Health Inc. Quidel...
BioCentury | Jun 15, 2020
Product Development

NCATS seeks to create hub for COVID-19 data; Regeneron reports preclinical data backing antiviral mAb cocktail

...COVID-19 Treatment Trial as well as investigator-initiated COVID-19 studies of the rheumatoid arthritis drug. Meanwhile, Cue Health Inc....
...LY3009104 (Compound #), INCB28050 (Former compound #), baricitinib (Generic), Olumiant (Other) Regeneron Pharmaceuticals Inc. Eli Lilly and Co. Cue Health Inc. Almac...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...the drug repurposing company’s proposed range. Cue Health raises $100M for COVID-19 test Diagnostics company Cue Health Inc....
...Co. Ltd. (Tokyo:4151) made an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Lantern Pharma Inc. Cue Health Inc. Pureos...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...Development Authority (BARDA) to develop diagnostics for respiratory pathogens and influenza. Cue Health Inc., San Diego, Calif. Alicia Parker Cue Health Inc....
Items per page:
1 - 7 of 7
BioCentury | Mar 25, 2021
Management Tracks

Slaoui resigns from Vaxcyte, Centessa; plus moves at HHS, Fate, Inotrem, Immuneering, SwanBio and more

...was a scientific co-founder of the company, succeeds Stan Abel, who will become SiteOne’s chairman. Diagnostics developer Cue Health Inc. hired...
...and managing partner of MRL Ventures Fund. BC Staff U.S. Department of Health and Human Services Fate Therapeutics Inc. Cue Health Inc. Inotrem...
BioCentury | Mar 17, 2021
Product Development

FDA gets explicit about asymptomatic screening tests

...outside of a testing program.” The March 5 authorization of a home test kit from Cue Health Inc....
...repeat home testing, which could enable more people to benefit from serial testing regimens. Karen Tkach Tuzman Cue Health Inc. U.S...
BioCentury | Mar 6, 2021
Product Development

Cue’s OTC home molecular test opens the door to routine self-screening

...for COVID-19 screening via a system that encourages repeat home testing.Performance metrics reported by manufacturer Cue Health Inc....
...positive samples from symptomatic users and 100% of positive samples from individuals without symptoms. Karen Tkach Tuzman Cue Health Inc. Lucira...
BioCentury | Nov 26, 2020
Product Development

U.S. government spending on Abbott BinaxNOW outstrips other rapid COVID-19 tests: Data Byte

...August , Abbott said it had shipped 7 million ID NOW tests.The COVID-19 molecular test from Cue Health Inc....
...tools for predicting who is most likely to spread SARS-CoV-2. Karen Tkach Tuzman Abbott Laboratories Becton Dickinson and Co. Cue Health Inc. Quidel...
BioCentury | Jun 15, 2020
Product Development

NCATS seeks to create hub for COVID-19 data; Regeneron reports preclinical data backing antiviral mAb cocktail

...COVID-19 Treatment Trial as well as investigator-initiated COVID-19 studies of the rheumatoid arthritis drug. Meanwhile, Cue Health Inc....
...LY3009104 (Compound #), INCB28050 (Former compound #), baricitinib (Generic), Olumiant (Other) Regeneron Pharmaceuticals Inc. Eli Lilly and Co. Cue Health Inc. Almac...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...the drug repurposing company’s proposed range. Cue Health raises $100M for COVID-19 test Diagnostics company Cue Health Inc....
...Co. Ltd. (Tokyo:4151) made an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Lantern Pharma Inc. Cue Health Inc. Pureos...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...Development Authority (BARDA) to develop diagnostics for respiratory pathogens and influenza. Cue Health Inc., San Diego, Calif. Alicia Parker Cue Health Inc....
Items per page:
1 - 7 of 7